Evidence map›Paper›PMID 36223640›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2022

Pim-1 kinase is a positive feedback regulator of the senescent lung fibroblast inflammatory secretome.

Ashley Y Gao, Ana M Diaz Espinosa, Fiorenza Gianì, Tho X Pham, Chase M Carver, Aja Aravamudhan, Colleen M Bartman, Giovanni Ligresti, Nunzia Caporarello, Marissa J Schafer and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. The Sixth Annual Symposium of the Midwest Aging Consortium.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Cellular Senescence: A Troy Horse in Pulmonary Fibrosis.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Ashley Y GaoDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-7963-5716
Ana M Diaz EspinosaDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
Fiorenza GianìDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
Tho X PhamDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Chase M CarverDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
Aja AravamudhanDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
Colleen M BartmanDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-3624-669X
Giovanni LigrestiDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Nunzia CaporarelloDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-3183-2868
Marissa J SchaferDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-1470-1583
Andrew J HaakDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-5323-253X
Mayo Clinic · US

Funding

BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3M
Mechanobiology of Lung FibrosisR01HL092961 · NHLBI · MAYO CLINIC ROCHESTER · PI Daniel J. Tschumperlin · 2009 to 2026
$8.0M
Systemic Cell Senescence as a Mediator of Brain Aging Through CirculationR01AG071686 · NIA · MAYO CLINIC ROCHESTER · PI SCHAFER, MARISSA JOY · 2021 to 2025
$2.4M
Optimization of fibroblast-selective inhibitors of YAP/TAZ as novel therapeutics for Pulmonary FibrosisR61HL161804 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HAAK, ANDREW JON, HEYNEN-GENEL, SUSANNE · 2022 to 2023
$1.3M
NHLBI NIH HHS R01 HL092961NHLBI NIH HHS R61 HL161804NHLBI NIH HHS T32 HL007035NIA NIH HHS R01 AG071686
6 · The paper itself

Abstract

Cellular senescence is emerging as a driver of idiopathic pulmonary fibrosis (IPF), a progressive and fatal disease with limited effective therapies. The senescence-associated secretory phenotype (SASP), involving the release of inflammatory cytokines and profibrotic growth factors by senescent cells, is thought to be a product of multiple cell types in IPF, including lung fibroblasts. NF-κB is a master regulator of the SASP, and its activity depends on the phosphorylation of p65/RelA. The purpose of this study was to assess the role of Pim-1 kinase as a driver of NF-κB-induced production of inflammatory cytokines from low-passage IPF fibroblast cultures displaying markers of senescence. Our results demonstrate that Pim-1 kinase phosphorylates p65/RelA, activating NF-κB activity and enhancing IL-6 production, which in turn amplifies the expression of

Indexed as

Idiopathic Pulmonary FibrosisPneumoniaCellular SenescenceCytokinesFibroblastsHumansLungNF-kappa BProto-Oncogene Proteins c-pim-1CytokinesNF-kappa BProto-Oncogene Proteins c-pim-1idiopathic pulmonary fibrosislung fibrosisPim kinasesecretomesenescence

Identifiers

PMID36223640
PMCPMC9744654
OpenAlexW4304807990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.